Which criteria should be analyzed to assess the commercial potential of an oncology treatment?
Sectorious pharmaceutical oncology reports analyze target patient population size, clinical development stage, efficacy and safety outcomes, biomarkers, targeted treatment lines, reimbursement policies, pricing, patent expirations and competitive intensity by cancer type. They help pharmaceutical companies, biotechs, investors and strategy teams compare opportunities across immunotherapies, targeted therapies, antibody-drug conjugates, cell therapies and combination treatments.